<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> patients often have an activated clotting system and are at increased risk for <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we analyzed tissue factor (TF) expression in 4 different human <z:mp ids='MP_0009153'>pancreatic tumor</z:mp> cell lines for the purpose of producing derivative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>We found that 2 of the lines expressed TF and released TF-positive microparticles (MPs) into the culture medium </plain></SENT>
<SENT sid="3" pm="."><plain>The majority of TF protein in the culture medium was associated with MPs </plain></SENT>
<SENT sid="4" pm="."><plain>Only TF-positive cell lines activated coagulation in <z:mp ids='MP_0003815'>nude</z:mp> mice, and this activation was abolished by an anti-human TF Ab </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 2 TF-positive lines, only one produced detectable levels of human MP TF activity in the plasma when grown orthotopically in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="6" pm="."><plain>Surprisingly, &lt; 5% of human TF protein in plasma from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-bearing mice was associated with MPs </plain></SENT>
<SENT sid="7" pm="."><plain>Mice with TF-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and elevated levels of circulating TF-positive MPs had increased <z:mp ids='MP_0005048'>thrombosis</z:mp> in a saphenous vein model </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, we observed no difference in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> weight between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-bearing and control mice in an <z:e sem="disease" ids="C0340757" disease_type="Disease or Syndrome" abbrv="">inferior vena cava stenosis</z:e> model </plain></SENT>
<SENT sid="9" pm="."><plain>The results of the present study using a xenograft mouse model suggest that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> TF activates coagulation, whereas TF on circulating MPs may trigger <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
</text></document>